Article Text

Download PDFPDF
Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer
  1. Yancheng Zhong, MS,
  2. Dan Gao, MS,
  3. Shiwei He, MS,
  4. Cijun Shuai, PhD and
  5. Shuping Peng, MD, PhD
  1. * The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Xiangya Hospital,
  2. The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute,
  3. Hunan Key Laboratory of Nonresolving Inflammation and Cancer, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China, and
  4. § State Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha, China.
  1. Address correspondence and reprint requests to Shuping Peng, MD, PhD, The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Cancer Research Institute, Xiangya Hospital, Central South University, Changsha, Hunan, China. E-mail: shuping{at}csu.edu.cn.

Abstract

Abstract Ovarian cancer is the leading cause of death among women with gynecologic malignancies. The development and progression of ovarian cancer are complex and a multiple-step process. New biomarker molecules for diagnostic and prognostic are essential for novel therapeutic targets and to extend the survival time of patients with ovarian cancer. Long noncoding RNAs (lncRNAs) are non–protein-coding transcripts longer than 200 nucleotides that have recently been found as key regulators of various biological processes and to be involved in the development and progression of many diseases including cancers. In this review, we summarized the expression pattern of several dysregulated lncRNAs (HOTAIR, H19, XIST, and HOST2) and the functional molecular mechanism of these lncRNAs on the initiation and progression of ovarian cancer. The lncRNAs as biomarkers may be used for current and future clinical diagnosis, therapeutics, and prognosis.

  • lncRNA
  • Ovarian cancer
  • HOTAIR
  • H19
  • XIST
  • HOST2
  • OC - ovarian cancer
  • lncRNA - long noncoding RNA
  • EOC - epithelial ovarian cancer
  • SOC - serous ovarian cancer
  • ORF - open reading frame
  • ncRNAs - noncoding RNAs
  • HOTAIR - HOX transcript antisense intergenic RNA
  • XIST - X inactive-specific transcript
  • Xi - X chromosome inactivation
  • MALAT1 - metastasis-associated lung adenocarcinoma transcript 1
  • MEG3 - maternally expressed gene 3
  • HOST2 - human ovarian cancer-specific transcript 2
  • ICR - imprinting control region
  • PRC2 - polycomb-repressive complex 2
  • EMT - epithelial-mesenchymal transition
  • IGFII - insulin-like growth factor II
  • UCA1 - urothelial cancer associated 1
  • MMP2 - matrix metallopeptidase 2
  • MMP9 - matrix metallopeptidase 9
  • NEAT - 1-nuclear paraspeckle assembly transcript 1
  • PSPC1 - protein-coding gene paraspeckle component 1

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.